Guangzhou Huateng Biomedical Technology Co., Ltd. (hereinafter referred to as “Huateng Biotechnology”) is a national high-tech and specialized & sophisticated enterprise dedicated to preclinical R&D technical services for biomedicines. Focusing on Contract Research Organization (CRO) services in the biomedical industry, the company centers on large animal models and provides one-stop preclinical efficacy and safety evaluation services for medical devices.
Headquartered in Huangpu District, Guangzhou, Huateng Bio owns a total laboratory area of over 20,000 square meters, with branch facilities located in Shenzhen, Foshan, Xiamen and Chongqing. The company has invested nearly 100 million RMB in high-end scientific research equipment and established multiple professional platforms, including pharmacodynamic and pharmacokinetic evaluation platforms, safety evaluation platforms, interventional and surgical operation platforms, imaging platforms, biological sample analysis and testing platforms, as well as biocompatibility testing platforms.
The company possesses a resource library of more than 300 animal models and a multi-platform R&D service system. It holds Laboratory Animal Use License and Laboratory Animal Production License, and has obtained defect-free AAALAC international accreditation, CNAS laboratory accreditation, and over 200 provincial and national CMA certified testing scopes, fully complying with FDA-GLP and OECD-GLP quality systems.
Huateng Bio has supported the successful global registration of over 300 innovative pharmaceutical and medical device products and facilitated the achievement transformation of more than 3,000 scientific research projects. Adhering to the mission of “Empowering Medical Innovation, Safeguarding Life and Health”, the company strives to deliver excellent integrated solutions for global biomedical R&D institutions.
official website：https://en.htscience.com